Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.11 USD | -7.42% | -2.20% | +81.54% |
May. 14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
May. 13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.54% | 288M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+47.19% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- BofA Securities Downgrades Inovio Pharmaceuticals to Underperform From Neutral With $2 Price Target